alyssin has been researched along with iberin in 1 studies
Studies (alyssin) | Trials (alyssin) | Recent Studies (post-2010) (alyssin) | Studies (iberin) | Trials (iberin) | Recent Studies (post-2010) (iberin) |
---|---|---|---|---|---|
7 | 0 | 3 | 28 | 1 | 17 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Boehm, J; Bolognese, B; Booth-Genthe, C; Callahan, JF; Carr, R; Davis, R; Dong, S; Foley, J; Galop, M; Graves, AP; Kerns, J; Kou, JP; Li, T; McCleland, B; Mentzer, M; Moody, CJ; Murar, CE; Podolin, PL; Qi, H; Sanchez, Y; Wilson, AJ; Wolfe, L; Yan, H; Yonchuk, J | 1 |
1 other study(ies) available for alyssin and iberin
Article | Year |
---|---|
Discovery of a crystalline sulforaphane analog with good solid-state stability and engagement of the Nrf2 pathway in vitro and in vivo.
Topics: Animals; Antioxidants; Cell Line; Cyclobutanes; Drug Discovery; Gene Expression; Heme Oxygenase-1; Humans; Isothiocyanates; Kelch-Like ECH-Associated Protein 1; Mice, Inbred C57BL; Molecular Structure; NF-E2-Related Factor 2; Oxidative Stress; Rats; Signal Transduction; Solubility; Structure-Activity Relationship; Sulfoxides; Thiocarbamates | 2019 |